Ocuvite Supplement Sales Boost Bausch & Lomb Pharmaceuticals Growth
This article was originally published in The Tan Sheet
Executive Summary
The Ocuvite vitamin line for eye health led Bausch & Lomb's pharmaceutical business to an approximately 18% increase in sales to $467 mil. in 2003, the company said
You may also be interested in...
Bausch & Lomb Sues Inverness For Ocular Vitamin Patent Infringement
Bausch & Lomb is seeking to enjoin IVC Industries, a subsidiary of Inverness Medical Innovations, from marketing products that allegedly infringe on its patent for Ocuvite PreserVision eye vitamins
Bausch & Lomb Sues Inverness For Ocular Vitamin Patent Infringement
Bausch & Lomb is seeking to enjoin IVC Industries, a subsidiary of Inverness Medical Innovations, from marketing products that allegedly infringe on its patent for Ocuvite PreserVision eye vitamins
Bausch & Lomb Sues Inverness For Ocular Vitamin Patent Infringement
Bausch & Lomb is seeking to enjoin IVC Industries, a subsidiary of Inverness Medical Innovations, from marketing products that allegedly infringe on its patent for Ocuvite PreserVision eye vitamins